No Detail Found!

Association of Serum P1np (N-terminal Propeptide of Type1 Collagen) and Bone Mineral Density (BMD) in Osteoporosis.

Author(s)
Afshan Iftikhar Ziauddin Medical University, Karachi, Pakistan
Tayeb Asim Ziauddin Medical University, Karachi, Pakistan
AnwarUl Islam Ziauddin Medical University, Karachi, Pakistan
Syed Tousif Ahmed Ziauddin Medical University, Karachi, Pakistan
Abstract
Objective: To access the variation of P1NP levels in normal, osteopenic and osteoporotic females and to study its correlation of with BMD in pre and post-menopausal women at hip and spine. Study Design: Cross sectional study. Place and Duration of Study: Ziauddin Hospital, Clifton Campus, Karachi during Jan to Dec 2017. Material and Methods: A sample of 267 randomly selected females that fulfilled the exclusion and inclusion criteria were included in the study. BMD was assessed by DEXA Scan while P1NP levels were measured using electrochemilluminescnet technique using Roche Cobas analyzer at Ziauddin hospital Karachi. Elecsys 2010, Modular analytics E170 Cobas e immunoassay analyzer. Data was collected using a self-designed Questionnaire. ANOVA was applied to compare mean differences of P1NP levels in pre and post-menopausal women in normal, osteopenic and osteoporotic groups. Regression analysis was used to determine association between P1NP level and BMD levels at spine and hip. Results: A significant negative correlation was found between P1NP and BMD at both the sites, while a strong association was established in P1NP and BMD spine, while for hip bone this association was non significant. Conclusions: Our study concludes that P1NP is a reliable biomarker for prediction of bone density of spine and is negatively correlated with the density.
Publication Details
Page(s) 357-362
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 2, Year: 2018

Request the full text from PASTIC

Keywords
P1NP, Osteopenia, Osteoporosis
References
DeepthiS,NarayanAR, 2015.Levels of serum calcium alkaline phosphatase and urinary hydroxyproline in post menopausal women,WJ Pharm Pharmaceutical Sci 4 919 -22
WheaterG,ElshahalyM,TuckSP,DattaHK,van LaarJM., 2013.The clinical utility of bone marker measurements in osteoporosis,J Transl Med 11 201 -
NaeemST,HussainR,RaheemA,SiddiquiI,GhaniF,KhanAH, 2016.Bone turnover markers for osteoporosis status assessment at baseline in postmenopausal Pakistani females,J Coll Physicians Surg Pak 26 408 -12
WaheedK,KhanumA,ButtA,EjazS,Obstet, 2016.Quality of Life after Menopause in Pakistani Women, 6 10003 -0932
AkhtarA,ShahidA,JamalAR,NaveedMA,AzizZ,BarkatN, 2016.Knowledge about osteoporosis in women of child bearing age (15-49 years) attending fauji foundation hospital Rawalpindi,Pak Armed Forces Med J 66 558 -63
KhoslaS. Minireview:, 2001.The opg/rankl/rank system,Endocrinology 142 5050 -5
ManolagasSC, 2000.Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis 1, 21 115 -37
DaiZ,WangR,AngLW,YuanJM,KohWP, 2016.Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population,Bone 83 171 -7
PisaniP,RennaMD,ConversanoF,CasciaroE,Di PaolaM,QuartaE, 2016.Major osteoporotic fragility fractures: Risk factor updates and societal impact,World J Orthop 7 171 -81
GhaziM,MounachA,NouijaiA,GhozlaniI,BennaniL,AchemlalL, 2007.Performance of the osteoporosis risk assessment tool in Moroccan men,J Clin Rheumatol 26 2037 -41
2011.Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards,Osteoporos Int 22 391 -420
VasikaranS,EastellR,BruyèreO,FoldesA,GarneroP,GriesmacherA, .Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards,Osteoporos Intl 201 391 -420
MukaiyamaK,KamimuraM,UchiyamaS,IkegamiS,NakamuraY,Kato H, 2015.Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover,Aging Clin Exp Res 27 413 -8
2011.ar ers of bone turnover for the prediction of fracture ris and monitoring of osteoporosis treatment need for international reference standard,s Osteoporos Int 22 391 -420
BhattaraiT,BhattacharyaK,ChaudhuriP,SenguptaP, 2014.Correlation of common biochemical markers for bone turnover, serum calcium, and alkaline phosphatase in post-menopausal women,The Malaysian journal of medical sciences: MJMS 21 58 -
MarinL,KoivulaMK,Jukkola-VuorinenA,LeinoA,RisteliJ, 2011.Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases,Ann Clin Biochem 48 447 -51
JagtapVR,GanuJV, 2011.Serum osteocalcin: A specific marker for bone formation in postmenopausal osteoporosis,Bone 2 5 -
JagtapVR,GanuJV,NaganeNS, 2011.BMD and serum intact osteocalcin in postmenopausal osteoporosis women,Indian J Clin Biochem 26 70 -3
SinghS,KumarD,LalAK, 2015.Serum osteocalcin as a diagnostic biomarker for primary osteoporosis in women,J Clin Diagn Res 9 RC04 -
BrownJP,AlbertC,NassarBA,AdachiJD,ColeD,DavisonKS, 2009.Bone turnover markers in the management of postmenopausal osteoporosis,Clin Biochem 42 929 -42
JungK,LeinM,StephanC,Von HösslinK,SemjonowA,SinhaP, 2004.Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications,Int J Cancer 111 783 -91
StokesFJ,IvanovP,BaileyLM,FraserWD, 2011.The effects of sampling procedures and storage conditions on short-term stability of blood-based biochemical markers of bone metabolism,Clin Chem 57 138 -40
HassagerC,JensenS,GotfredsenA,ChristiansenC., 1991.The impact of measurement errors on the diagnostic value of bone mass measurements: theoretical considerations,Osteoporos Int 1 250 -6
MillerPD, 2012.Bone strength and surrogate markers: the first, second, and third fiddle,J Bone Miner Res 27 1623 -6
BjarnasonN,HenriksenE,AlexandersenP,ChristgauS,HenriksenD,ChristiansenC, 2002.Mechanism of circadian variation in bone resorption,Bone 30 307 -13
BaxterI,RogersA,EastellR,PeelN., 2013.Evaluation of urinary Ntelopeptide of type I collagen measurements in the management of osteoporosis in clinical practice,Osteoporos Int 24 941 -7
MelkkoJ,HellevikT,RisteliL,RisteliJ,SmedsrødB, 1994.Clearance of NH2-terminal propeptides of types I and III procollagen is a physiological function of the scavenger receptor in liver endothelial cells,Int J Clin Exp Med 179 405 -12
EastellR,KregeJH,ChenP,GlassEV,ReginsterJY, 2006.Development of an algorithm for using PINP to monitor treatment of patients with teriparatide,Curr Med Res Opin 22 61 -6
TerreniA,PezzatiP, 2012.Biochemical markers in the follow-up of the osteoporotic patients,Clin Cases Miner Bone Metab 9 80 -4
ChenP,SatterwhiteJH,LicataAA,LewieckiEM,SiposAA,MisurskiDM, 2005.Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis,J Bone Miner Res 20 962 -70
NaylorK,EastellR, 2012.Bone turnover markers: use in osteoporosis,Nat Rev Rheumatol 8 379 -89
RenisM,LobreglioD,CongedoP,MontinaroMC,MuratoreM,LobreglioG, 2018.Assessment of serum vitamin B12 levels and other metabolic parameters in subjects with different values of bone mineral density,J Clin Med Res 10 233 -
NomuraY,YoshizakiA,YoshikataH,KikuchiR,SakakibaraH,ChakiO, 2013.Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values,J Bone Miner Metab 31 644 -51
ZhaoJ,XiaW,NieM,ZhengX,WangQ,WangX, 2011.The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study,Menopause 18 1237 -43
KharroubiA,SabaE,SmoomR,BaderK,DarwishH.,Serum, 2017.- hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women,Arch Osteoporos 12 13 -
ScarianoJ,GlewR,Bou-SerhalC,ClemensJ,GarryP,BaumgartnerR, 1998.Serum levels of cross-linked N-telopeptides and aminoterminal propeptides of type I collagen indicate low bone mineral density in elderly women,Bone 23 471 -7
LiuSZ,TianLF,XuP,ZhuangGH,ZhengF,TianJ, 2011.Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women,Curr Mol Biol Rep 38 939 -48
HuWW,ZhangZ,HeJW,FuWZ,WangC,ZhangH, 2013.Establishing reference intervals for bone turnover markers in the healthy shanghai population and the relationship with bone mineral density in postmenopausal women,Int J Endocrinol 513925 -
Kuču, 2013.The utility of procollagen t pe1 N-terminal propeptide for the bone status assessment in postmenopausal wome,nBosn J Basic Med Sci 13 259 -
GaoC,QiaoJ,LiS,YuW,HeJ,FuW, 2017.The levels of bone turnover markers 25 (OH) D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China,Osteoporos Intl 28 211 -8
0

Citations

0

Downloads

140

Views